What to Do When You Reach Goal Weight on Wegovy

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Reaching your goal weight on Wegovy represents a genuine health achievement—studies show GLP-1 receptor agonists help people lose an average of 15–22% of body weight over 68 weeks. But success at goal weight brings a new challenge: how do you maintain those results without regaining weight? PlexusDx explains your options.

Why Weight Regain Happens After Stopping Semaglutide

Once you stop taking semaglutide (the active ingredient in Wegovy), your body's appetite-control signals begin to shift back toward baseline. Research published in The New England Journal of Medicine found that people who discontinued semaglutide regained approximately two-thirds of lost weight within one year. This isn't a failure of willpower—it's biology. Semaglutide works by activating GLP-1 receptors in your brain and gut, reducing hunger and increasing fullness. When the medication stops, those signals fade.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Maintenance Strategies at Goal Weight

Medical consensus supports three main approaches once you reach goal weight on semaglutide. First, you can continue the medication at the lowest effective dose to prevent regain—this is sometimes called 'maintenance dosing.' Second, you can discontinue medication and rely entirely on behavioral changes (diet, exercise, sleep, stress management). Third, you can use a combination approach: stop medication, implement lifestyle modifications, and restart if weight begins to creep back up. Your choice depends on your personal preference, insurance situation, and how your body responds.

Studies show that people who maintain weight loss best combine moderate medication use with consistent lifestyle practices. A 2022 analysis found that participants who kept taking lower doses of GLP-1 medications alongside structured nutrition support maintained 85% of weight loss after two years. PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and offers flexibility to adjust your regimen as your needs change—your dose may need to go up or down, but your price won't.

Personalized Maintenance With Genetic Insights

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The genetic test is available for $298. Results help answer critical questions: Will you maintain weight loss naturally after stopping medication, or do you need ongoing support? Should you pursue a microdose protocol versus standard dosing? Are there specific dietary or lifestyle changes most likely to work for your genetics? This precision approach removes guesswork from long-term weight management.

PlexusDx Options for Long-Term Weight Stability

PlexusDx offers multiple compounded GLP-1 options to support your maintenance phase. Compounded semaglutide injection ($189/month starting) provides the same active ingredient as Wegovy but at a more flexible cost structure with no insurance requirement. For those seeking a lower-intensity approach, the Microdose GLP-1 Protocol ($129/month flat) delivers a gentler dose designed specifically for weight maintenance rather than active weight loss. This option works well for patients who've reached goal and want minimal medication support while building sustainable habits.

All PlexusDx medications come from licensed 503A compounding pharmacies and are available to patients in all 50 states without a membership fee. HSA and FSA accounts are eligible, making treatment accessible regardless of insurance status. Your healthcare provider can monitor your progress and adjust your maintenance regimen based on real-world results—if you're stable at goal weight, your dose can decrease; if weight begins to return, your plan can be modified immediately.

Building Lifestyle Foundations for Lasting Success

Medication is most effective when paired with sustainable behavior change. Research shows that people who maintain weight loss long-term combine moderate physical activity (150+ minutes weekly), adequate protein intake (25–30% of daily calories), consistent sleep (7–9 hours nightly), and stress management. GLP-1 medications make these changes easier by reducing hunger and cravings, but they don't eliminate the need for them. At goal weight, you have the mental clarity and physical energy to reinforce these habits without fighting constant appetite signals.

Work with a registered dietitian or nutritionist to design a maintenance meal plan that feels sustainable. Many people find that the eating patterns they developed during active weight loss naturally continue because they feel good and control hunger. The key difference at goal weight is shifting from a calorie deficit to a calorie balance—eating enough to maintain your new weight while keeping the habits that got you there. PlexusDx providers can connect you with nutrition resources and monitor your progress through follow-up assessments.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Should I stay on semaglutide after reaching goal weight?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What does clinical evidence say about weight regain after stopping GLP-1 medications?

A landmark clinical trial found that participants who stopped semaglutide regained approximately two-thirds of their weight loss within one year, while those who continued maintenance therapy kept their weight stable. This suggests that for most people, ongoing GLP-1 support is more effective than stopping abruptly. Individual genetics and lifestyle factors influence outcomes, which is why personalized assessment matters.

Can I switch to a lower dose of semaglutide after hitting goal weight?

Yes. Many patients successfully transition to lower maintenance doses once they reach goal weight. PlexusDx compounded semaglutide injection is priced flat at $189/mo (or $149/mo on the 6-month plan) regardless of dose, so you have the flexibility to adjust based on your provider's guidance. Your price won't change if your dose decreases—you only pay the monthly rate for your treatment tier.

What is the PlexusDx Microdose GLP-1 Protocol?

The Microdose GLP-1 Protocol ($129/month flat) is a lower-intensity compounded GLP-1 option designed for weight maintenance rather than active weight loss. It's ideal for patients who've already reached goal and want minimal ongoing support. This option comes from licensed 503A compounding pharmacies and is available in all 50 states without insurance.

How can genetic testing help with weight maintenance?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (FTO and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.